http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2023503068-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C39-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C37-68 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 |
| filingDate | 2020-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2023-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2023503068-A |
| titleOfInvention | cannabidiol-type cannabinoid compounds |
| abstract | The present invention relates to cannabidiol (CBD)-type cannabinoid compounds for use as pharmaceuticals. Cannabidiol-C1 (CBD-C1), a CBD-type cannabinoid, is a naturally occurring cannabinoid that can be present in trace amounts in cannabis plants. Additionally, five cannabinoids can be produced by synthetic means and methods for producing CBD-C1 are described herein. In addition, disclosed herein are data demonstrating the efficacy of CBD-C1 in disease models. |
| priorityDate | 2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.